LLY News and Press, Eli Lilly and Company From 03/07/24

2024-03-07 19:06:31 ET More on Novo Nordisk Novo Nordisk: My 'Hold' Thesis For 2024 - The Premium Must Be Justified Novo Nordisk, A Very Healthy Pharma Stalwart Novo Nordisk: SOTP After Impressive FY23 And Weight Loss Going Mainstream, Maintain Buy Biggest st...

2024-03-07 09:33:18 ET More on Labcorp Laboratory Corporation of America Holdings (LH) Q4 2023 Earnings Call Transcript Laboratory Corporation of America Holdings 2023 Q4 - Results - Earnings Call Presentation Laboratory Corporation of America Q4 2023 Earnings Previe...

Lilly's Newest Phase of Get Better Campaign Challenges Misperceptions About Obesity Care PR Newswire Two new films draw attention to the importance of treating obesity as a disease and the appropriate use of anti-obesity medications INDIANAPOLIS , March 7, 20...

2024-03-07 07:06:17 ET More on Novo Nordisk Novo Nordisk, A Very Healthy Pharma Stalwart Novo Nordisk: SOTP After Impressive FY23 And Weight Loss Going Mainstream, Maintain Buy Novo Nordisk: Irrational Exuberance Isn't Worth The Risk Cigna in pact with Novo, ...

2024-03-07 06:43:36 ET More on Cigna Cigna: Trimming The Fat And Staying Focused Cigna: Big Buybacks And Total Return Potential The Cigna Group (CI) Q4 2023 Earnings Call Transcript Dividend Roundup: Southwest Airlines, Cigna, Deere, Gap, and more Pha...

2024-03-06 17:40:54 ET More on Bristol-Myers Squibb Company , Johnson & Johnson, etc. Eli Lilly and Co (LLY) Cowen's 44th Annual Health Care Conference (Transcript) Pfizer Inc. (PFE) TD Cowen 44th Annual Health Care Conference Johnson & Johnson (JNJ) Cow...

2024-03-06 16:13:40 ET Summary Apogee Therapeutics, Inc. positive interim results achieved from Phase 1 study of APG777 for Atopic Dermatitis and Phase 2 study initiation and additional data expected in 1st half of 2024 and 2025, respectively. Company has potential to overcom...

2024-03-06 14:15:05 ET Eli Lilly and Co (LLY) Cowen's 44th Annual Health Care Conference March 06, 2024 09:10 AM EST Company Participants Anat Ashkenazi - EVP & CFO Andrew Adams - Vice President of New Therapeutic Modalities & Scientific Leader Conferen...

2024-03-06 11:31:43 ET More on Eli Lilly Eli Lilly: Will It Be The First Ever Trillion-Dollar Drug Company? Eli Lilly: Yes, It Is Too Late To Join The Party Eli Lilly: Very Strong Fundamentals, But Market Is Euphoric Eli Lilly said to have tapped National Res...

2024-03-06 05:50:00 ET Just when the weight-loss drug market was heating up, the temperature rose even more. Eli Lilly (NYSE: LLY) is already giving Novo Nordisk (NYSE: NVO) a run for its money with the approval in the fourth quarter of 2023 of Zepbound. Now another rival co...